Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe Hypoglycaemia
Conditions:   Diabetes Mellitus, Type 1;   Hypoglycemia Unawareness;   Hypoglycemia
Intervention:   Device: Dexcom G6 CGM
Sponsors:   Imperial College London;   London Ambulance Service
Not yet recruiting

Tue, 20 Nov 2018 12:00:00 EST


Conversation Map and Diabetes in Pakistan
Conditions:   Diabetes Mellitus;   Diabetes;   Self Efficacy;   Diabetes Mellitus, Type 2
Intervention:   Behavioral: Diabetic Conversation Map
Sponsor:   Rubina Qasim
Not yet recruiting

Tue, 20 Nov 2018 12:00:00 EST


Effects of WB-EMS and Protein Supplementation on LBM Maintenance During Intended Weight Loss
Condition:   Overweight, Obesity and Other Hyperalimentation
Interventions:   Dietary Supplement: Protein;   Behavioral: Walking;   Behavioral: WB-EMS application
Sponsor:   University of Erlangen-Nürnberg Medical School
Active, not recruiting

Tue, 20 Nov 2018 12:00:00 EST


Improving Islet Transplantation Outcomes With Gastrin
Condition:   Diabetes Mellitus, Type 1
Interventions:   Biological: Allogenic Human Islet Cells;   Drug: Gastrin 17
Sponsors:   City of Hope Medical Center;   University of California, Los Angeles
Not yet recruiting

Tue, 20 Nov 2018 12:00:00 EST


Management of Glycemia Following a Pizza Meal
Condition:   Diabetes Mellitus, Type 1
Interventions:   Other: the patients ate a pizza that fermented for 8 hours;   Other: the patients ate a pizza that fermented for 24 hours
Sponsors:   University of Campania "Luigi Vanvitelli";   Federico II University
Completed

Tue, 20 Nov 2018 12:00:00 EST


Medication Adherence Clinical Decision Support
Conditions:   Hyperlipidemias;   Hypertension;   Diabetes;   Medication Nonadherence
Interventions:   Other: Adherence-enhanced clinical decision support;   Behavioral: ReachOut Adherence intervention
Sponsors:   HealthPartners Institute;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

Tue, 20 Nov 2018 12:00:00 EST


Pharmacist and Data Driven Quality Improvement in Primary Care
Condition:   Medication Safety
Intervention:   Behavioral: P-DQIP
Sponsors:   University of Dundee;   NHS Tayside
Recruiting

Tue, 20 Nov 2018 12:00:00 EST


Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes
Conditions:   Diabetes Mellitus, Type 2;   Hypertension
Interventions:   Drug: Perindopril and Amlodipine;   Drug: Perindopril-indapamide
Sponsors:   Yaounde Central Hospital;   University of Yaounde 1
Completed

Tue, 20 Nov 2018 12:00:00 EST


A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: MEDI0382;   Drug: Placebo
Sponsor:   MedImmune LLC
Not yet recruiting

Mon, 19 Nov 2018 12:00:00 EST


Achieving the Quadruple Aim by Reducing Burnout
Condition:   Burnout, Professional
Intervention:   Behavioral: Compassion Curriculum
Sponsor:   Providence Health & Services
Completed

Mon, 19 Nov 2018 12:00:00 EST


An Investigational Study of Experimental Medication Supaglutide Injection Given With the Placebo in Healthy Participants
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Supaglutide injection;   Drug: Placebo
Sponsors:   Shanghai Innogen Pharmaceutical Technology Co.,Ltd;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School;   Tigermed Consulting Co., Ltd;   Mosim Co., Ltd.;   Linking Truth Technology Co., Ltd.;   Medidata Solutions
Not yet recruiting

Mon, 19 Nov 2018 12:00:00 EST


Comparative Evaluation Of 1.2% Atorvastatin and 1.2% Simvastatin Gel Local Drug Delivery And Redelivery In Chronic Periodontitis Subjects With Diabetes Mellitus: A Randomized Controlled Clinical Trial.
Condition:   Chronic Periodontitis Wth Diabetes Mellitus
Interventions:   Drug: ATORVASTATIN;   Drug: SIMVASTATIN;   Drug: PLACEBO
Sponsor:   Government Dental College and Research Institute, Bangalore
Completed

Mon, 19 Nov 2018 12:00:00 EST


Comparison Between Sleeve Gastrectomy and Loop Bipartition (Short-term Outcomes)
Condition:   Loop Bipartition
Intervention:   Procedure: loop bipartition
Sponsor:   Assiut University
Not yet recruiting

Mon, 19 Nov 2018 12:00:00 EST


Effects of Non-alcoholic Beer in Patients With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Dietary Supplement: Water;   Dietary Supplement: Non-alcoholic beer
Sponsors:   Universidade do Porto;   CINTESIS - Centre for Health Technology and Services Research;   NOVA Medical School
Recruiting

Mon, 19 Nov 2018 12:00:00 EST


PDD in Type 2 Diabetes w/wo Diastolic Dysfunction
Conditions:   Diabetes Mellitus, Type 2;   Diastolic Dysfunction
Interventions:   Drug: Nesiritide Injection;   Drug: LCZ 696;   Drug: Placebos
Sponsor:   Mayo Clinic
Recruiting

Mon, 19 Nov 2018 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA warns marketers of products labeled as dietary supplements that contain tianeptine for making unproven claims to treat serious conditions, including opioid use disorder
FDA issued warning letters issued to two companies for the illegal marketing of products labeled as dietary supplements that contain tianeptine.

Tue, 20 Nov 2018 15:36:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on FDA’s updates to Medical Device Safety Action Plan to enhance post-market safety
FDA provides updates on medical device safety action plan describing recent actions we’ve taken to enhance device safety including implementation of NEST and registries on women’s health.

Tue, 20 Nov 2018 11:30:00 -0500


FDA approves first treatment specifically for patients with rare and life-threatening type of immune disease
The FDA approved Gamifant (emapalumab-lzsg) for the treatment of pediatric (newborn and above) and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) who have refractory, recurrent or progressive disease or intolerance with conventional HLH therapy. This FDA approval is the first for a drug specifically for HLH.

Tue, 20 Nov 2018 09:32:00 -0500


Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim for consuming oils with high levels of oleic acid to reduce coronary heart disease risk
FDA issues a qualified health claim for oleic acid oils based on data showing it reduces cholesterols levels.

Mon, 19 Nov 2018 12:54:00 -0500


FDA approves new drug to treat travelers’ diarrhea
FDA approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

Fri, 16 Nov 2018 17:07:00 -0500


Statement from USDA Secretary Perdue and FDA Commissioner Gottlieb on the regulation of cell-cultured food products from cell lines of livestock and poultry
The U.S. Department of Agriculture and U.S. Food and Drug Administration are announcing that USDA and FDA should jointly oversee the production of cell-cultured food products derived from livestock and poultry.

Fri, 16 Nov 2018 16:43:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s efforts to hold industry accountable for fulfilling critical post-marketing studies of the benefits, safety of new drugs
The FDA is committed to making sure post-market studies are transparent to the public and that industry is fulfilling their PMRs and PMCs.

Fri, 16 Nov 2018 11:38:00 -0500


Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce animal testing through a study aimed at eliminating the use of dogs in certain trials
Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to reduce use of animals through a study aimed at eliminating the use of dogs in certain trials

Fri, 16 Nov 2018 11:11:00 -0500


FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
The FDA expanded the approved use of Adcetris (brentuximab vedotin) injection in combination with chemotherapy for adult patients with certain types of peripheral T-cell lymphoma (PTCL). This is the first FDA approval for treatment of newly diagnosed PTCL, and the agency used a new review program to complete the approval more quickly.

Fri, 16 Nov 2018 10:40:00 -0500


Results from 2018 National Youth Tobacco Survey show dramatic increase in e-cigarette use among youth over past year
New findings from the National Youth Tobacco Survey show that more than 3.6 million middle and high school students were current (past 30 day) e-cigarette users in 2018.

Thu, 15 Nov 2018 10:26:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News